Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Far costlier than I care to admit.
Exactly right.
When you're losing an argument and the facts are against you, that's when you resort to name calling.
Still SMH after reading the comment of the company claiming this is a "Sound Investment". The same company that diluted for years and resorted to toxic financing. But hey folks, your investment is sound. That is rich. It's no secret Penny stocks are notoriously not sound investments but one with this track record? Was that suppose to be a joke? Was the Principals of DBMM trying their hand at comedy?
Mother Of All Fake News:
Quote:
Please continue to be patient as the process continues. Your investment is sound. The Management believes in the Company’s mission and its stalwart shareholders. We expect neither to be disappointed.
So Sad and laughable at the same time.
Reggie, time to grow a pair, get honest, and go out on your own. Earn an honest living. You're talented and DBMM has used you to fleece the shareholders long enough. Or do you no longer have a conscious like the Principals?
so called "cheap shares" are like the turkish delight the white witch of Narnia gave edmund in the classic written by CS Lewis.
It really can't be more clear. Judge acted to protect the public and investors from losing more money. His 15 page Court Document shines the light on the nefarious shennanigans of Linda Perry. he wasn't putting up with it and let her know. There is NO way she's going to get someone to invest $250,000 in this. She already owes Asher and that was at draconian rates which further crushes the shareholders.
HUGE RED FLAG: Although Neil Gray, of the United Kingdom, has—officially—been the chairman and executive director of Digital Brand since April 1, 2010, he has not actually been involved with the company since 2014. Tr. 77-79. Reggie James, also a U.K. national, is a managing director and operates all aspects of the technical side of the business. Tr. 74, 76. His pay accrues monthly, as does Perry’s, but neither has ever drawn a paycheck from the company. Tr. 76-77.
ARE YOU KIDDING ME???? Reggie has never drawn a paycheck from the company? How are you eating and surviving Reggie? You’re too talented to continue on like this. Go find a legit Job. Don’t be an accomplice to gross negligence and defrauding shareholders out of their investments and retirements.
Is Reggie getting paid by Stylar Holdings which is a subsidiary of DBMM? But wouldn't this show up in the previous filings. So many smoke and mirrors. Kinda like the Wizard of OZ. Desperately Trying to make it sound and look so much bigger than what it is. Sad and at the same time cruel to the shareholders who keep hoping against hope.
FOR THE PROTECTION OF THE INVESTORS:
Considering the company’s delinquencies, which include more than two years of
missed filings, and the absence of a sufficient defense for Digital Brand’s repeated
violations, it is necessary and appropriate for the protection of investors to revoke
the registration of each class of its registered securities.8
DBMM asked for a "Hardship Exemption" which was denied by the Court:
3.5. Hardship Exemption7
Digital Brand contends that the Commission should grant it a hardship
exemption based on a “thread of events” of “epic bad luck.” Resp. Post-Hr’g Br. at 3-
5; Answer ¶ 10; Answer to Mot. for Ruling on the Pleadings ¶ 11. As discussed in
the Findings of Fact, Digital Brand’s “epic bad luck” consisted of (1) various
problems with multiple auditors, requiring a re-audit of the company’s financial
statements, and (2) fallout from loans from a high-interest lender that went bad.
Resp. Post-Hr’g Br. at 3-4.
Digital Brand is not entitled to a hardship exemption under the plain language
of the regulation.
Really REALLY Important Investors read the following from the Commission / Judge: (it completely contradicts Linda Perry's Claim the company is profitable and this is all just a big misunderstanding)
3.4. Remedial Action
Digital Brand has made no efforts to remedy its past violations by filing any of
its delinquent periodic reports. Nor can one accept its representations that it will
comply in the future, because it lacks the resources to do so. According to its annual
reports, from 2003 through 2014 Digital Brand never made a profit. There is no
12
evidence that Digital Brand has made a profit since 2014.6 Those ongoing losses
impair its ability to hire and pay for the bookkeeping services provided by Boisseau
and hamper the retention and payment of an auditor. Although Digital Brand has
engaged a new auditor, its assurances against future violations are unrealistic. Its
new auditor has nothing to audit because the evidence is that Digital Brand’s
bookkeeper, Boisseau, has not prepared the books for Digital Brand past the period
of the annual report for the period ended August 31, 2015. Tr. 34-35. Moreover,
Digital Brand has not hired any other firm to prepare pre-audit accounting
packages for the delinquent reports. Tr. 105. Digital Brand cannot remedy its
violations until it obtains the resources to pay for Boisseau or some other
bookkeeper’s services, and to pay an auditor to audit the bookkeeper’s financial
statements for the company. Digital Brand offered no credible evidence that it has
obtained, or even has a path to obtaining, sufficient resources in the immediate
future.
Further, it is too late for Digital Brand to catch up on its multiple delinquent
periodic reports—even if it could—and avoid revocation. In Absolute Potential, the
Commission found, among other things, that even where the delinquent issuer
became current in its periodic reports during summary disposition briefing, the
public interest still required revocation of its securities registration as a deterrent
to other issuers that might become delinquent. 2014 WL 1338256, at *3-8; see
Citizens Capital Corp., Exchange Act Release No. 67313, 2012 WL 2499350, at *2-7
(June 29, 2012) (revoking registration despite issuer’s efforts to become current);
Calais Res. Inc., Exchange Act Release No. 67312, 2012 WL 2499349, at *2-7 (June
29, 2012) (same); see also Law Enf’t Assocs. Corp., Initial Decision Release No. 487,
2013 WL 2039311, at *2, *4 (ALJ May 15, 2013) (issuer revoked even though it filed
all delinquent reports after Section 12(j) proceeding was instituted).
6 If Digital Brand has made a profit since 2014, it made a deliberate choice not to
put those profits toward satisfying its reporting obligations, making it even more
culpable.
Nearly 102% owned by Institutions. Key take away's from recent Healthcare Conferece & Fireside Chat with Esperion:
https://twitter.com/search?vertical=default&q=%24espr&src=typd&lang=en
(scroll down to post by Kaushik)
Buying Shares of DBMM is like running into the far corner of a basement of a house that is engulfed in flames in the hopes you might find something of value. It's called a fool's errand for a reason.
Agreed. Not professional. Can you imaging the Principals of this company asking any reputable financial institution for money? DBMM is 2 years delinquent on filings, Owe $250K, and look at a 10 year chart where the value of the stock has gone from around $30,000 to less than a penny. NO financial institution is going to lend ANY money to DBMM even at draconian terms cause they know they'll never see one red cent. So why these companies do is sell discounted shares which get dumped on the market. Everyone thinks they are getting a great deal when the person selling shares is already selling at a deep discount.
Great questions StockBarber. I'll say 1 thing about Linda. She has a great vocabulary. Having a great vocabulary and being smart does not make one a good person or a good business person. The shareholders have been CRUSHED over the entire life of this so called business venture. At the worst, Linda is a liar that will have to answer to for her lies someday. There is a moral justice and she'll have to face up to it. At best she is incompetent and her good intentions have been nothing short of disasterous for the shareholders. The road to Hell is paved with good intentions. This has been the road to investment hell for many. The company can't even afford press releases so they have a Website where the put out a blog that is suppose to suffice as a Press Release? It's a joke. For what, to sell shares?? The front page of their website has a forward looking statement disclaimer! Always CYA with forward looking statements. Then you can say virtually anything and get away with it. The company is 2 years delinquent filing. They need a ton of money and if the company is so profitable as Linda Claims, then why can't they pay for filings? Because of an audit? Give me a break. It's a ruse and share selling scheme. Look at a 10 chart. Can someone post a 10 year chart for everyone to see? Past performance IS an pretty good predictor of future performance when you have the same Principals involved.
I briefly skimmed over the document but looks like a smart Judge had had enough. Did I read it correctly the company hadn't been profitable since 2004? She had NO Documentation that she could get the money. She was stalling and the Judge saw right through it. There is no way she was going to come up with $250,000 plus $61,000 to get all the filings current and the judge knew it. (they were 2+ years behind!) Maybe If she had documentation he may have may have raised a suspicious eyebrow and looked it over. I'm almost surprised she didn't and include a forward looking statement to the judge to cover herself. Like all the times the shareholders were lead to believe the many silly & flawed business proposals / plans that never came to fruition which were accompanied with forward looking statements to cover themselves. So now it appears the Judge awarded the company to Asher. Not sure exactly what it means for the shareholders but probably not good IMO. If you count it as a lesson learned and move on and make wiser investments, then maybe it was a painful lesson that will someday bear profits.
I Truly am Sorry for all the shareholders. The 10 year chart pretty much tells the story. I'm too embarrassed to admit how much I lost before I took my losses, moved on, and stopped posting here years ago. Thankfully the ruse is up. May God forgive me for the time and money I wasted believing the lies wrapped up in slick forward looking statements. Best wishes to everyone.
If you could go back to 2002 you'd probably see the share price at $1,000,000 now worth less than a penny. Folks, if the stock was worth $25,000 just 5 years ago and now less than a Penny, What does that tell you about the competence of the Directors / ownership / management? The only thing they are competent at is DILUTION. Selling YOU worthless shares. They hide their schemes behind forward looking statements. Nothing of substance ever materializes with this "company." Is there a trading platform that will let you short Penny stocks?
Merck announced after hours yesterday it will not be seeking to bring it's developmental drug Anacetrapib (CETP Inhibitor) to market.
Merck now has a clear cardiovascular drug candidate void in its pipeline & with MRK’s #Zetia, ESPR is the logical drug candidate 2 fill it.
Long ESPR
Chart looking decent.... MACD upswing...
Presentation on Wednesday, June 7, 2017 at 10:30 a.m. Eastern Time
ANN ARBOR, Mich., May 31, 2017 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc. (ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C), today announced that president and chief executive officer, Tim M. Mayleben, will present at the Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June 7, 2017 at 10:30 a.m. Eastern Time.
Me thinks they will find & announce Partners (US and Europe/Asia) or be bought out by Big Pharma in the next 6 months...
Either way, I expect the stock to be north of $60 by EOY.
To get an idea of how much Dilution that has occured since 2004...
https://www.barchart.com/stocks/quotes/DBMM/technical-chart#/technical-chart?plot=BAR&volume=total&data=MO&density=H&pricesOn=1&asPctChange=0&logscale=0&sym=DBMM&grid=1&height=500&studyheight=100
Doesn't get any worse. Sad.
Bempedoic Acid also lowers inflammation which could be a huge benefit as well. Same Lipid Experts behind Lipitor (Dr Roger Newton) is behind ETC-1002. I follow AniuStudent on Twitter who has been dead on with this stock. He seems to know a lot about the upside and risks and likes his chances with ESPR. Pfizer has probably nearly 20Bil in cash and cash equivalents. Esperion states that 181 Million People in the US, Europe, and Japan suffer from High LDL-C. At 3,000 a year, it doesnt take much Market share to have a huge winner. 10% of 40Mil Patients with High LDL-C are Statin Intolerent. That market alone is worth Pfizer paying Esperion $4Bil, if Esperion would sell it for that. Drug has a clear path to market and could see $100+ in 2 years with No Buyout. I personally think History is about to repeat itself with Esperion and Pfizer. All the best to all the Longs. Was a good day today.
$ESPR:PM up 2.3%
Market now a believer of bempedoic acid which
-Lowers LDL
-Lowers hsCRP
-Works in statin in-intolerant patients
-Orally effective
-CHEAP (Bempedoic Acid only $3,000 to treat vs $14,500 Statins)
Someone (Very Knowledgeable on Biotech) I follow on another Message board said something to the effect:
With $AMGN's repatha being priced out of mkt, bemp may b the only game in town4 0.20x 70million pts.
If you take 20% of 70Mil Patients x $3,000 = $42Billion Drug!!
Now, $ESPR Bempedoic Acid Drug = $42Billion / 23Mil shares = $1,826 Share price. Can you see why $AMGN , $MRK would want to Purchase Esperion? Hence TODAY's VOLUME.
Me thinks we go HIGHER tomorrow
ESPR: Bempedoic Acid CVOT 75% chance of success. Proven Mechanism, Clear Path to Approval; Team of Lipid Experts... Well Funded.
In June of 2015, Analyst's had PTs from JMP $177, UBS $140 & Barclays $150. When ESPR was trading $100+.
Bempedoic acid was safe & effective in statin-intolerant patients -20% of all w/ lipid disorder. That's the advantage
Esperion Benefit from Trump Administration?
https://www.forbes.com/forbes/welcome/?toURL=https://www.forbes.com/sites/matthewherper/2017/03/20/is-esperion-therapeutics-going-to-benefit-from-a-trump-fda/&refURL=https://t.co/DawlFX1ubm&referrer=https://t.co/DawlFX1ubm
Glad I backed up the truck on Friday.
Stock traded 100+ previously prior to FDA requiring CVOT. Now with Clear path to Approval, could get past $100 again. Investors also have to wonder if someone like AMGN, MRK, or ? would jump in and buy Esperion and their renown team of Lipid Experts.
Big Short Position also caught in today's squeeze. Traded 106,000 shares after hours and I think ended around $41.60 up 30cents.
$ESPR' bempedoic acid:
Orally active
lowers LDL & hsCRP - helps reduce inflammation
clean safety profile
will b a lot CHEAPER than PCSK9i drugs
Do your own DD & GL!
Here's a good DewTheDil Link:
http://www.esperion.com/targeting-unmet-needs/
Want to see where the share price will be in 3 years? Pull up a 3 year chart and watch History repeat itself.
Just my honest opinion. Due your own Due Dilligence.
I was here way back when it did make it to a nickle. The company then Diluted it into Oblivion which is what they do best. It's an ATM Machine for them and an Endless Black Hole for Investors.
http://www.bioworld.com/content/fourier-clinical-benefit-yes-cost-benefit-no-0
Repatha's cost would be about $14,500 a year. ESPR ETC-1002 is only $3,000 a year. And Orally vs. Shot. And less Inflammation.
Over reaction.
And Happy St. Patricks Day... All 20 mins left of it.
Guys, Where's the best link for finding largest increase of Daily Call / Put Activity for a Stock?
$ESPR bempedoic acid ETC-1002:
-much lower cost,
-lowers hsCRP/inflammation
-better safety profile
-orally effective
-suited4 statin-intolerant Pts
Hi Roy, Sorry I just saw your post. I'm not on very regularly either. You guys are the Pro's on here. I still have much learning and really don't have the time to put into it. I've had some big wins and losses. Hope the Chemo is doing it's job and wish you a full recovery.
AAPL bought Oct 14 $120 calls .31 avg
Great buy on your Amazon Calls! bought Oct XOM calls a couple weeks ago and did well with those today.
Grabbed some SPY Calls early in the day to avg down and green by EOD. Holding over night.
Sold AMZN calls at $14. Had averaged down to about $2.50 each. Thanks for the trade idea Beer!
Filled Sell to Close 8 AMZN Sep 23 2016 785.0 Call Limit 14.00 -- -- 09:38:55 09/22/16
Filled Sell to Close 1 AMZN Sep 23 2016 785.0 Call Limit 14.00 -- -- 09:38:53 09/22/16
Filled Sell to Close 1 AMZN Sep 23 2016 785.0 Call Limit 14.00 -- -- 09:38:53 09/22/16
Grabbed a couple at 3.50 and a couple more at 2.55. make pretty nice bank last week holding to Friday. Will see if it happens again.
Thanks for the TSLA 220 Put idea. Made $180 on 4 puts.
Nice video CT.
Resistance at $11.75 and $12.65
Support at $10.75 and $9.25
REN files with the SEC S-8 that they issued 1,620,000 shares of Common Stock at $6.45 for an Employee Incentive. Why no press release to explain it? Seem a little shady?